Home · Open Lab · Lot RGX-26-RGNX-731
RGX-26-RGNX-731Superseded
Epitalon · 50 MG · Longevity Research · COA NS-2026-05213

Release test results

99.645%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 50.4 mg
Related impurities (total)0.355%
Endotoxin<1.0 EU/mg
HPLC retention time9.69 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundEpitalon
Presentation50 MG
Lot numberRGX-26-RGNX-731
COA numberNS-2026-05213
Test date27 Mar 2026
Release date30 Mar 2026
Independent labNordicstar Labs
StatusSuperseded

Epitalon — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-RGNX-106810 MGJul 5, 202699.654%Current
RGX-26-RGNX-106950 MGJul 4, 202699.576%Current
RGX-26-RGNX-731 this lot50 MGMar 27, 202699.645%Superseded
RGX-26-RGNX-73210 MGMar 26, 202699.721%Superseded
RGX-25-RGNX-63210 MGDec 27, 202599.683%Superseded
RGX-25-RGNX-63150 MGDec 20, 202599.690%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →